VPIM
Vanguard Personalized Indexing Management’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
202,312
+45,959
| +29% | +$711K | 0.04% | 428 |
|
|
2025
Q1 | $2.32M | Buy |
156,353
+55,729
| +55% | +$829K | 0.03% | 442 |
|
|
2024
Q4 | $1.33M | Buy |
100,624
+24,495
| +32% | +$324K | 0.02% | 638 |
|
|
2024
Q3 | $1.08M | Buy |
76,129
+5,961
| +8% | +$84.8K | 0.02% | 728 |
|
|
2024
Q2 | $906K | Sell |
70,168
-22,911
| -25% | -$296K | 0.02% | 723 |
|
|
2024
Q1 | $1.29M | Buy |
93,079
+28,466
| +44% | +$395K | 0.03% | 538 |
|
|
2023
Q4 | $922K | Buy |
64,613
+9,102
| +16% | +$130K | 0.02% | 694 |
|
|
2023
Q3 | $859K | Sell |
55,511
-8,261
| -13% | -$128K | 0.03% | 640 |
|
|
2023
Q2 | $1M | Buy |
63,772
+3,844
| +6% | +$60.4K | 0.03% | 569 |
|
|
2023
Q1 | $989K | Buy |
59,928
+24,965
| +71% | +$412K | 0.03% | 538 |
|
|
2022
Q4 | $545K | Sell |
34,963
-17,229
| -33% | -$269K | 0.02% | 773 |
|
|
2022
Q3 | $677K | Buy |
52,192
+10,006
| +24% | +$130K | 0.03% | 658 |
|
|
2022
Q2 | $592K | Buy |
42,186
+9,373
| +29% | +$132K | 0.03% | 734 |
|
|
2022
Q1 | $470K | Buy |
32,813
+16,170
| +97% | +$232K | 0.02% | 857 |
|
|
2021
Q4 | $227K | Buy |
16,643
+13
| +0.1% | +$177 | 0.01% | 957 |
|
|
2021
Q3 | $272K | Buy |
16,630
+1,672
| +11% | +$27.3K | 0.02% | 799 |
|
|
2021
Q2 | $252K | Sell |
14,958
-2,488
| -14% | -$41.9K | 0.03% | 805 |
|
|
2021
Q1 | $319K | Sell |
17,446
-2,082
| -11% | -$38.1K | 0.05% | 480 |
|
|
2020
Q4 | $355K | Sell |
19,528
-1,268
| -6% | -$23.1K | 0.08% | 304 |
|
|
2020
Q3 | $371K | Buy |
20,796
+3,323
| +19% | +$59.3K | 0.1% | 233 |
|
|
2020
Q2 | $313K | Buy |
+17,473
| New | +$313K | 0.14% | 180 |
|